Badreddin Edris's Net Worth
$16.7 Million
Who is Badreddin Edris?
Badreddin Edris has an estimated net worth of $16.7 Million. This is based on reported shares across multiple companies, which include Edgewise Therapeutics, Inc., and SpringWorks Therapeutics, Inc..
SEC CIK
Badreddin Edris's CIK is 0001786966
Past Insider Trading and Trends
2023 was Badreddin Edris's most active year for acquiring shares with 4 total transactions. Badreddin Edris's most active month to acquire stocks was the month of December. 2024 was Badreddin Edris's most active year for disposing of shares, totalling 9 transactions. Badreddin Edris's most active month to dispose stocks was the month of December. 2023 saw Badreddin Edris paying a total of $0.00 for 296,117 shares, this is the most they've acquired in one year. In 2021 Badreddin Edris cashed out on 64,000 shares for a total of $5,421,369.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $38.75
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.01% | -20.00K |
$40.65 | -$812,954.35 | 229.6K |
Scheduled
|
Sep 3
| ||
Form 4
| -7.42% | -20.00K |
$40.07 | -$801,371.89 | 249.6K |
Scheduled
|
Jun 3
| ||
Form 4
| +13.65% | 32.38K |
$39.92 | -$396,646.22 | 269.6K |
Jan 4 - Jan 8
| |||
Form 4
| -0.62% | -1.48K |
$26.41 | -$39,166.03 | 237.22K |
Jan 7
| |||
Form 4
| +14.74% | 30.67K |
$27.52 | -$91,531.52 | 238.71K |
Jan 5 - Jan 6
| |||
Form 4/A
| -0.57% | -1.85K |
$56.06 | -$103,823.12 | 325.81K |
Jan 7
| |||
Form 4
| -0.77% | -2.53K |
$56.06 | -$141,887.86 | 325.13K |
Jan 7
| |||
Form 4
| +8.66% | 26.12K |
—
|
—
| 327.67K |
Jan 6
| |||
Form 4
| -9.59% | -32.00K |
$85.35 | -$2,731,088.00 | 301.54K |
Scheduled
|
Jul 1
| ||
Form 4
| -10.90% | -32.00K |
$84.07 | -$2,690,281.60 | 261.54K |
Scheduled
|
Jan 25
| ||
Form 4
| +4.63% | 13K |
—
|
—
| 293.54K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |